Is Merck Stock a Bargain Buy?
Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda. During the ...
Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form
Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA ...
Here is Why Jim Cramer Is Bullish About Merck (MRK)
We recently published a list of Jim Cramer Focused On These 9 Stocks Recently. In this article, we are going to take a look ...
Opinion
Biotech stocks have been hit by 'DOGE' and other fears. Why they're a great value now.
For greater potential upside, consider earlier-stage smid-cap biotech names. Small- and midcap biotech stocks are riskier, but have been hardest hit in the sector's decline. "Smid-cap biotech looks ...